Andrew Segerdahl

Andrew Segerdahl is a Senior Postdoctoral Researcher at the Nuffield Department of Clinical Neurosciences (NDCN), University of Oxford, affiliated with the FMRIB and P.A.I.N research groups. His work focuses on unraveling the neural mechanisms of pain perception using advanced neuroimaging techniques across brain, brainstem, and spinal cord systems.

His research targets the fundamental biology of pain, investigating how nociceptive input transforms into subjective pain experiences and becomes dysfunctional in chronic conditions. He employs multimodal neuroimaging approaches including arterial spin labeling and functional MRI to study pain across spatial and temporal scales, with strong emphasis on translational applications bridging animal models and human chronic pain patients through UK-USA collaborations.

Publication analysis reveals three dominant research thrusts: methodological innovations in neuroimaging data processing (particularly arterial spin labeling calibration), clinical pain state imaging for biomarker development, and health services research examining fibromyalgia hospitalization patterns, costs, and geographical disparities in England. His work consistently integrates computational modeling with clinical neuroscience to address pain's complexity.

Segerdahl operates within Oxford's FMRIB and P.A.I.N research ecosystems, contributing to the university's leadership in clinical neurosciences through interdisciplinary teams focused on developing novel pain interventions and diagnostic frameworks.